Small-Molecule Inhibitors of the Tumor Suppressor Fhit

Sandra Lange1, Stephan M Hacker1,2, Philipp Schmid1

  • 1Department of Chemistry, Konstanz Research School-Chemical Biology, University of Konstanz, Universitätsstrasse 10, 78457, Konstanz, Germany.

Insights

Researchers developed a high-throughput screen to find small-molecule inhibitors of the tumor suppressor Fhit. This screen identified potent inhibitors crucial for studying Fhit

Area of Science:

  • Oncology
  • Biochemistry
  • Molecular Biology

Background:

  • The tumor suppressor Fhit and its substrate diadenosine triphosphate (Ap3A) play critical roles in cancer development and progression.
  • Fhit possesses Ap3A hydrolase activity, cleaving Ap3A into AMP and ADP, which is thought to terminate Fhit-mediated signaling.
  • Mechanisms regulating Fhit's catalytic activity and its growth-suppressive functions remain largely unknown.

Purpose of the Study:

  • To develop a high-throughput screening method for identifying small-molecule inhibitors of Fhit enzymatic activity.
  • To provide valuable tools for investigating the tumor-suppressive functions of Fhit.

Main Methods:

  • Development and implementation of a high-throughput screen (HTS) assay.
  • Identification of inhibitor compounds targeting Fhit activity.
  • Synthesis and in vitro characterization of selected inhibitor derivatives.

Main Results:

  • Two distinct clusters of small-molecule inhibitors significantly reduced Fhit activity by over 90%.
  • Synthesized derivatives demonstrated potent in vitro inhibitory activity with IC50 values in the nanomolar range.

Conclusions:

  • The developed HTS assay successfully identified potent inhibitors of Fhit enzymatic activity.
  • These novel inhibitors serve as valuable chemical probes for further research into Fhit's role in cancer.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.0K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.9K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
10.0K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
6.2K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K